Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Location
Florham Park, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305% % -58%
Quick Ratio 3.9% % -4.9%
Debt-to-equity -182% % 45%
Return On Equity 77% % -63%
Return On Assets -94% % -2.7%
Operating Margin -145% % 87%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71,138,440 shares 4%
Common Stock, Shares, Outstanding 71,043,149 shares 4%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 73,396,435 shares 14%
Weighted Average Number of Shares Outstanding, Diluted 73,396,435 shares 14%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $147,190,000 USD 460%
Cost of Revenue $18,767,000 USD 334%
Research and Development Expense $33,870,000 USD -13%
Operating Income (Loss) $213,475,000 USD 26%
Nonoperating Income (Expense) $61,075,000 USD -19%
Net Income (Loss) Attributable to Parent $274,550,000 USD 19%
Earnings Per Share, Basic -3 USD/shares 34%
Earnings Per Share, Diluted -3 USD/shares 34%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $135,156,000 USD -60%
Inventory, Net $3,611,000 USD 16%
Assets, Current $207,783,000 USD -44%
Property, Plant and Equipment, Net $1,156,000 USD -30%
Operating Lease, Right-of-Use Asset $2,694,000 USD 223%
Other Assets, Noncurrent $1,693,000 USD 0.06%
Assets $240,289,000 USD -38%
Accounts Payable, Current $1,075,000 USD -85%
Accrued Liabilities, Current $65,349,000 USD 83%
Contract with Customer, Liability, Current $24,344,000 USD 21%
Liabilities, Current $93,123,000 USD 43%
Contract with Customer, Liability, Noncurrent $348,984,000 USD 8.2%
Operating Lease, Liability, Noncurrent $2,123,000 USD
Other Liabilities, Noncurrent $11,500,000 USD 7%
Liabilities $662,823,000 USD 15%
Retained Earnings (Accumulated Deficit) $1,463,110,000 USD -23%
Stockholders' Equity Attributable to Parent $422,534,000 USD -126%
Liabilities and Equity $240,289,000 USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $84,930,000 USD -23%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $18,000 USD 55%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 71,043,149 shares 4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $84,948,000 USD -44%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,226,000 USD 40%
Deferred Tax Assets, Valuation Allowance $255,342,000 USD 45%
Deferred Tax Assets, Gross $255,492,000 USD 45%
Operating Lease, Liability $2,714,000 USD 299%
Payments to Acquire Property, Plant, and Equipment $18,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid $3,786,000 USD 439%
Property, Plant and Equipment, Gross $4,317,000 USD 3%
Operating Lease, Liability, Current $591,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $719,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $686,000 USD 34%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 73%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,072,000 USD 4561%
Lessee, Operating Lease, Liability, to be Paid, Year Three $736,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $195,225,000 USD 63%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40,000,000 shares 0%
Unrecognized Tax Benefits $3,452,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Four $753,000 USD
Operating Lease, Payments $200,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $177,000 USD -17%
Deferred Tax Assets, Net of Valuation Allowance $150,000 USD -56%
Share-based Payment Arrangement, Expense $29,796,000 USD -29%
Interest Expense $58,068,000 USD 54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%